INTERCEPT-T2D members convened at the 60th Annual EASD Congress in Madrid to engage with experts on inflammation and type 2 diabetes and strengthen their collaboration.
Members of the INTERCEPT-T2D consortium were present at the 60th Annual EASD Congress, held from September 9 to 13, 2024, in Madrid.
During that week, they attended scientific sessions on inflammation and type 2 diabetes, engaged with researchers, clinicians, and industry representatives, and strengthened the consortium’s internal cohesion.